1st Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$103,945
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy in House and Senate for Bills to Reauthorize the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). Advocacy in Congress for HHS/BARDA funding in FY-2013 budget (Senate Labor-HHS Appropriations and House Labor-H Appropriations. Education for Members of Congress and Staff on biodefense medical countermeasures, especially anthrax recombinant vaccine.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and Government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2504 (112th), S. 1855 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.